ops-2071
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01925521)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ops-2071
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05923892 | Phase 2 | Aug 2, 2023 | Huazhong University of Science and Technology, Otsuka |
| NCT03850509 | Phase 2 | Jun 4, 2019 | IQVIA, Otsuka |
| NCT02473393 | Phase 2 | Jun 1, 2015 | Otsuka |
| NCT02440633 | Phase 1 | May 1, 2015 | Otsuka |
| NCT01925521 | Phase 1 | Aug 1, 2013 | Otsuka, Seoul National University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 5 | 5 | 2 | 2013 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2023 |
| IQVIA | For profit | 1 | 0 | 1 | 2019 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1